Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression (Q44649765)

5 December 2017

Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression (English)

1 reference

5 December 2017

Ninghua Yao

1

1 reference

5 December 2017

Dengfu Yao

2

1 reference

5 December 2017

Li Wang

3

1 reference

5 December 2017

Zhizhen Dong

4

1 reference

5 December 2017

Wei Wu

5

1 reference

5 December 2017

Liwei Qiu

6

1 reference

5 December 2017

Xiaodi Yan

7

1 reference

5 December 2017

Dandan Yu

8

1 reference

5 December 2017

Jie Chen

9

1 reference

5 December 2017

Wenli Sai

10

1 reference

5 December 2017

Haijian Zhang

11

1 reference

5 December 2017

Junlin Yang

12

1 reference

5 December 2017

10 June 2012

1 reference

5 December 2017

1 reference

5 December 2017

33

1 reference

5 December 2017

5

1 reference

5 December 2017

1767-1776

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-012-0436-x

5 December 2017

0 references

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Genomics and signaling pathways in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

A vision for the future of genomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Antiviral immunity directed by small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Anoikis resistance and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0436-X

Specific molecular markers in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma

1 reference

12 December 2020

Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis.

1 reference

12 December 2020

Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model

1 reference

12 December 2020

A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis.

1 reference

12 December 2020

Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma

1 reference

12 December 2020

Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression

1 reference

12 December 2020

Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development

1 reference

12 December 2020

10.1007/S13277-012-0436-X

Identifiers

DOI

1 reference

5 December 2017

1 reference